Epigenetic 'Switches' in Cirrhosis: How DNA Methylation Shapes Disease Progression

MARKOPOLO: Noisy World, Silent Killer - How Noise Drives Cardiovascular Disease by Andreas Daiber

A Standardized Rapid Animal Model for MASLD/MASH with Translational Potential

MICROB-PREDICT - Multi-compartment metabolomics to stratify cirrhotic patients (Christophe Junot)

MICROB-PREDICT - Albumin reduces inflammation & protects against multi-organ injury (Alex Phillips)

MICROB-PREDICT - Leukotoxin 9,10-DiHOME drives immunosuppression in ACLF (C. López, B. Contreras)

MICROB-PREDICT - Dávid Tornai (University of Debrecen) on secretory IgA in gut barrier dysfunction

MICROB-PREDICT - Peter Treit (Max Planck Institute of Biochemistry) on biomarkers in liver disease

MICROB-PREDICT - Lore van Espen (Katholieke Universiteit Leuven) on the gut virome in liver disease

MICROB-PREDICT - Biomarkers in cirrhosis: Christophe Junot (CEA) speaks with Marko Korenjak (ELPA)

MICROB-PREDICT - Cristina López Vicario & Bryan Contreras Herrera (FCRB) on lipid mediators in ACLF

MICROB-PREDICT - Alexandra Phillips (University College London) on rodent models of cirrhosis & ACLF

MICROB-PREDICT - Antimicrobial Resistance: Lindsey Edwards (KCL) speaks with Marko Korenjak (ELPA)

MICROB-PREDICT - Camila Alvarez-Silva (University of Copenhagen) on metabolite biomarkers of ACLF

MICROB-PREDICT - Nikolaj Torp (Odense Universitetshospital): Albumin treatment in cirrhosis & ACLF

Tiny Messengers, Big Impact: Large Extracellular Vesicles in Acute Liver Decompensation

Emergency Granulopoiesis in Liver Failure: When the Immune System Goes into Chaos

Data repositories and their access and publication rights | Masterclass in bioinformatics

The Role of LSECtin in Regulating Inflammation in Advanced Chronic Liver Disease | DECISION Keynote

MICROB-PREDICT - Serum villin-1, a tell-tale sign of gut-barrier failure in cirrhosis (Dávid Tornai)

DECISION Masterclass: Clinical Bioinformatics | Núria Planell, Cris Sanchez, and David Gomez-Cabrero

MICROB-PREDICT - The predictive role of immunoglobulins in gut barrier dysfunction (Dávid Tornai)

Introduction to the QSPainRelief Database (by Daan van Valkengoed, Leiden University, NL)

QSPainRelief Masterclass - Opioid Receptors & Quantitative Systems Pharmacology (Andrea Bedini)

DECISION Keynote Lecture by Prof. Richard Moreau - Inflammation in AD and ACLF

DECISION: Was ist die COMBAT Studie? Fragen und Antworten mit Dr. med. Maike Pollmanns

DECISION: What is the COMBAT trial? Questions and answers with Dr. Kohilan Gananandan

DECISION: ¿Qué es el estudio COMBAT? Preguntas y respuestas con Dr. Joan Genescà

DECISION : Qu'est-ce l'essai COMBAT ? Questions et résponses avec Pr. Pierre-Emmanuel Rautou

DECISION: Qual è lo studio COMBAT? Domande e risposte con Prof. Paolo Caraceni

ClustALL: Stratifying Decompensated Cirrhosis Patients – Explained by Sara Palomino

A-TANGO Masterclass: Reimbursement in Healthcare (Louise Perrault, IMAC)

MICROB-PREDICT - The gut virome and bacteriophages in decompensated liver cirrhosis (Lore Van Espen)

MICROB-PREDICT - Blood-biomarker to stratify cirrhosis patients in the ALB-Trial (Nikolaj Torp)

MICROB-PREDICT - Multi-omics biomarkers for early identification of Pre-ALCF (Camila Alvarez-Silva)

MICROB-PREDICT - Metagenomics-Metaproteomics Pipeline for Biomarker Discovery in ACLF (Peter Treit)

A-TANGO - Poster: Alcohol-related liver failure versus infection-induced ACLF (A. Kerbert & J. Pohl)

A-TANGO - Poster at EASL: Evolving patterns in the clinical burden of liver cirrhosis (Julian Pohl)

A-TANGO Masterclass 2023 - Economic evaluations in liver disease (by Prof. Isabelle Durand-Zaleski)

QSPainRelief Masterclass - Patient Partnerships in Research (Deirdre Ryan from Pain Alliance Europe)

DECISION Masterclass: Health economic studies in liver diseases by Prof. Isabelle Durand-Zaleski

REPO-TRIAL: Pre-clinical validation of in-silico therapeutic predictions (Dr. Ana Isabel Casas)

REPO-TRIAL: Clinical validation of in silico trial prediction (Prof. Dr. Harald Schmidt)

REPO-TRIAL: Applied Bioinformatics and Diagnostics (Cristian Nogales, PhD)

REPO-TRIAL: Patents: What they are, what you have to look out for (Dr. Hermann Mucke)

DECISION Project: Advancing Treatment Strategies for Decompensated Cirrhosis

DECISION Keynote Lecture by Prof. Paolo Angeli - Natural History of Decompensation

QSPainRelief Masterclass - Human biomarkers of nociception (André Mouraux)

QSPainRelief Masterclass - Smart data in pharmacokinetics and pharmacodynamics (Liesbeth de Lange)

REPO-TRIAL: Project Overview & Main outcomes (Prof. Dr. Harald Schmidt, MD, PhD, PharmD, FESC)

REPO-TRIAL: Patent Possibilities in Drug Repurposing (by Kolja Adamczyk)

REPO-TRIAL: NeDRex use case "Inflammatory Bowl Disease"

REPO-TRIAL: NeDRex use case "Pulmonary Embolism"

REPO-TRIAL: Introduction to NeDRex

REPO-TRIAL: Dr. med. Benedikt Frank on the regulatory complexity to get EU clinical trials approved

REPO-TRIAL: Dr. Hermann Mucke on the project's patent applications and extraordinary team effort

REPO-TRIAL: Prof. Dr. med. Daniel Sedding on the regulatory hurdles for clinicial trials in Germany

DECISION Masterclass 2022 - Overview of the effects of LMWH in cirrhosis (Agustín Albillos Martínez)

A-TANGO Masterclass 2022 - Medical Device Design, Biotechnology and Entrepreneurship (Daniel Green)

A-TANGO Masterclass 2022 - Advances in the Treatment of Cirrhosis and ACLF (Prof. Dr. Thomas Berg)